cardiovascular-agents and tartaric-acid

cardiovascular-agents has been researched along with tartaric-acid* in 7 studies

Other Studies

7 other study(ies) available for cardiovascular-agents and tartaric-acid

ArticleYear
Improvement of intestinal absorption of P-glycoprotein substrate by D-tartaric acid.
    Drug metabolism and pharmacokinetics, 2006, Volume: 21, Issue:5

    The purpose of the present experiment was to examine the effects of D-tartaric acid (TA) on intestinal drug absorption under both in situ and in vitro experimental conditions. In the in vitro diffusion chamber experiments, TA (10 mM) added to the mucosal side of rat colon significantly decreased rhodamine123 (Rho 123) transport from the serosal to mucosal side. Since TA has been shown to change the integrity of the epithelial tight junctions in rat colon at low pH conditions, resulting in improved paracellular drug transport, the effect of TA on membrane resistance was examined at pH 7.4 in the present study. It was found that membrane resistance, an indicator of paracellular integrity, did not change at pH 7.4. In the in situ loop method, TA (20 mM) increased the absorption of Rho123 in both ileum and colon but not in jejunum. TA (20 mM) also increased the absorption of daunorubicin in the ileum, but TA (20 mM) did not change the expression level of P-glycoprotein (P-gp). TA (20 mM) significantly inhibited excretion of i.v.-administered Rho123 and daunorubicin into the ileal lumen. In conclusion, for the first time we demonstrated that TA increases the intestinal absorption of P-gp substrates Rho123 and daunorubicin, possibly by modulating the P-gp function without changing the expression level of P-gp in the rat intestine.

    Topics: Animals; Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Blotting, Western; Cardiovascular Agents; Colon; Daunorubicin; Diffusion Chambers, Culture; Fluorescent Dyes; Ileum; Injections, Intravenous; Intestinal Absorption; Jejunum; Male; Rats; Rats, Wistar; Rhodamine 123; Tartrates; Verapamil

2006
[Pentapyrrolidinium tartrate in arterial hypertension].
    Minerva medica, 1957, Sep-29, Volume: 48, Issue:78

    Topics: Cardiovascular Agents; Humans; Hypertension; Muscle Relaxants, Central; Tartrates

1957
[Methylergobasine tartrate in therapy of third stage of labor].
    Rivista di ostetricia e ginecologia, 1955, Volume: 10, Issue:2

    Topics: Cardiovascular Agents; Ergot Alkaloids; Female; Humans; Labor, Obstetric; Oxytocics; Pregnancy; Tartrates; Work

1955
NEW AND unofficial remedies: methylergonovine tartrate.
    Journal of the American Medical Association, 1954, Mar-06, Volume: 154, Issue:10

    Topics: Cardiovascular Agents; Ergot Alkaloids; Humans; Methylergonovine; Oxytocics; Tartrates

1954
Clinical evaluation of methylergonovine tartrate (semisynthetic ergonovine).
    American journal of obstetrics and gynecology, 1953, Volume: 65, Issue:5

    Topics: Cardiovascular Agents; Ergonovine; Ergot Alkaloids; Female; Humans; Labor, Induced; Labor, Obstetric; Methylergonovine; Oxytocics; Pregnancy; Tartrates; Work

1953
[Induction of labor by tartrate of methyl-ergobasine].
    La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris, 1953, Nov-06, Volume: 29, Issue:68

    Topics: Cardiovascular Agents; Ergot Alkaloids; Female; Humans; Labor, Induced; Labor, Obstetric; Oxytocics; Pregnancy; Tartrates

1953
Treatment of migraine; with special reference to ergotamine tartrate-caffeine rectal suppositories.
    Postgraduate medicine, 1952, Volume: 11, Issue:5

    Topics: Caffeine; Cardiovascular Agents; Ergot Alkaloids; Ergotamine; Humans; Migraine Disorders; Suppositories; Tartrates

1952